Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Yabao Pharmaceutical Co. Inc.

www.yabao.com.cn

Latest From Yabao Pharmaceutical Co. Inc.

China Declares Outbreak Past Peak, But Drug Makers Far From Recovery

Clinical studies in hiatus, marketing on hold, demand directionless and supply disrupted. Pharma firms in China say it’s likely the good old days may never come back.

Coronavirus COVID-19 Research & Development

New Phase II Data Bolster vTv Therapeutics’ Glucokinase Activator Aspirations

The future for glucokinase activation is looking brighter after fresh data on vTv’s oral adjunct to insulin therapy in type 1 diabetes.

Clinical Trials Companies

Asia Executives To Watch: Alcon Japan New President, AZ International EVP

Autumn has brought a flurry of personnel changes with Kyowa FujiFilm getting a new president and AZ a new executive vice president for the international region. Fosun and the medtech firm, Median Technologies, have also seen personnel movement.

Asia Pacific Appointments

Asia Executives To Watch: Alcon Japan New President, AZ International EVP

Autumn has brought a flurry of personnel changes with Kyowa FujiFilm getting a new president and AZ a new executive vice president for the international region. Fosun and the medtech firm, Median Technologies, have also seen personnel movement.

Asia Pacific Appointments
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Gynecological, Urological
  • Inflammation
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Yabao Pharmaceutical Co. Inc.
  • Senior Management
  • Peng Wang, PhD, Pres., R&D
    Luo Shizhong, Head, Partnering
  • Contact Info
  • Yabao Pharmaceutical Co. Inc.
    Phone: 10-58561099
    1 Guoying Bldg., Nan Xiao St., Xizhimen
    9th Fl.
    Xicheng District, Beijing, 100035
    China
UsernamePublicRestriction

Register